Bupropion and Restless Legs Syndrome

• Status: Completed
• Trial end date: 2009-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if bupropion will improve the symptoms of restless legs syndrome (RLS).

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: East Tennessee State University
• Treatments: Bupropion

Criteria

Inclusion Criteria:

• clinical diagnosis of Restless Legs Syndrome

• Severity Scale score 15 or higher

Exclusion Criteria:

• History of seizures

• History of alcohol use greater than 2 drinks per day or occasional binges of 5 or more drinks per day

• Suicidal thoughts/ideations

• Inability to return for follow up appointments at 3 and 6 weeks

• Lack of access to telephone

• Eating disorder

• Age less than 18

• Pregnancy

• Unwillingness or inability to discontinue any RLS medications